
### [DOID:10595](http://purl.obolibrary.org/obo/DOID_10595)
**Label:** Charcot-Marie-Tooth disease

**Subclasses:** [DOID:0050539](http://purl.obolibrary.org/obo/DOID_0050539) (Charcot-Marie-Tooth disease type 2), [DOID:0050541](http://purl.obolibrary.org/obo/DOID_0050541) (Charcot-Marie-Tooth disease type 4), [DOID:0050542](http://purl.obolibrary.org/obo/DOID_0050542) (Charcot-Marie-Tooth disease type X), 

**Corr. equiv. classes:** [OMIM:118230](http://purl.obolibrary.org/obo/OMIM_118230), [Orphanet:64746](http://www.orpha.net/ORDO/Orphanet_64746), [Orphanet:64747](http://www.orpha.net/ORDO/Orphanet_64747), [Orphanet:64749](http://www.orpha.net/ORDO/Orphanet_64749), [OMIM:604484](http://purl.obolibrary.org/obo/OMIM_604484), 

**Class expressions from DL-Learner:**

- [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 60.82%
- [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%
- [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 60.82%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 60.82%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) 60.82%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 60.82%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%
- [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) 60.82%
- [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 60.82%
- [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%
- [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 60.82%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 60.82%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 60.82%


